New Insight Into the Redox Properties of Uremic Solute Indoxyl Sulfate as a Pro- and Anti-Oxidant

Therapeutic Apheresis and Dialysis

Volumn 15, Issue 2, 2011, Pages 129-131

  Miyamoto, Yohei ^a   Watanabe, Hiroshi ^a,b   Otagiri, Masaki ^a,c   Maruyama, Toru ^a,b  

^a Graduate School of Pharmaceutical Sciences   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c SOJO UNIVERSITY   (Japan)

Author keywords

Antioxidant; Chronic kidney disease; Indoxyl sulfate; Pro oxidant; Uremic toxin

Indexed keywords

6 HYDROXYMELATONIN; ALBUMIN; AMYLOID BETA PROTEIN; AST 120; HYDROXYL RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDICAN; INDOLEPROPIONIC ACID; MELATONIN; ORGANIC ANION TRANSPORTER 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; PYRROLE DERIVATIVE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SEROTONIN; SUPEROXIDE; UREMIC TOXIN; XANTHINE; XANTHINE OXIDASE;

ALBUMIN BLOOD LEVEL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROLIFERATION; CHRONIC KIDNEY DISEASE; DISEASE COURSE; ENDOTHELIUM CELL; HUMAN; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY TUBULE CELL; MESANGIUM CELL; NEUROPROTECTION; NEUTROPHIL; NONHUMAN; OPOSSUM; OXIDATION; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UMBILICAL VEIN; UREMIA; VASCULAR ENDOTHELIUM; WOUND HEALING;

ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; HUMANS; INDICAN; KIDNEY DISEASES; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; UREMIA;

EID: 79953055289     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2010.00884.x     Document Type: Article

References (22)

1. Himmelfarb J. Linking oxidative stress and inflammation in kidney disease: which is the chicken and which is the egg? Semin Dial 2004;17:449-54.
2. Barreto FC, Barreto DV, Liabeuf S etal. European Uremic Toxin Work Group (EUTox). Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol 2009;4:1551-8.
3. Gelasco AK, Raymond JR. Indoxyl sulfate induces complex redox alterations in mesangial cells. Am J Physiol Renal Physiol 2006;290:F1551-8.
4. Motojima M, Hosokawa A, Yamato H, Muraki T, Yoshioka T. Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-κB and free radical in proximal tubular cells. Kidney Int 2003;63:1671-80.
5. Dou L, Jourde-Chiche N, Faure V etal. The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells. J Thromb Haemost 2003;5:1302-8.
6. Shimoishi K, Anraku M, Kitamura K etal. An oral adsorbent, AST-120 protects against the progression of oxidative stress by reducing the accumulation of indoxyl sulfate in the systemic circulation in renal failure. Pharm Res 2007;24:1283-9.
7. Enomoto A, Niwa T. Roles of Organic Anion Transporters in the Progression of Chronic Renal Failure. Therap Apher Dial 2007;11:S27-31.
8. Miyamoto Y, Iwao Y, Tasaki Y etal. The uremic solute indoxyl sulfate acts as an antioxidant against superoxide anion radicals under normal-physiological conditions. FEBS Lett 2010;2584:2816-20.
9. Schrier RW, Shapiro JI, Chan L, Harris DC. Increased nephron oxygen consumption: potential role in progression of chronic renal disease. Am J Kidney Dis 1994;23:176-82.
10. Alfrey AC. Role of iron and oxygen radicals in the progression of chronic renal disease. Am J Kidney Dis 1994;23:183-7.
11. Dou L, Bertrand E, Cerini C etal. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int 2004;65:442-51.
12. Tumur Z, Niwa T. Indoxyl Sulfate Inhibits Nitric Oxide Production and Cell Viability by Inducing Oxidative Stress in Vascular Endothelial Cells. Am J Nephrol 2009;29:551-7.
13. Muteliefu G, Enomoto A, Jiang P, Takahashi M, Niwa T. Indoxyl sulphate induces oxidative stress and the expression of osteoblast-specific proteins in vascular smooth muscle cells. Nephrol Dial Transplant 2009;24:2051-8.
14. Yoshida Y, Sakai T, Ise M. Effects of oral adsorbent in the rat model of chronic renal failure. Nephron 1992;62:305-14.
15. Aoyama I, Miyazaki T, Niwa T. Preventive effects of an oral sorbent on nephropathy in rats. Miner Electrolyte Metab 1999;25:365-72.
16. Owada A, Nakao M, Koike J, Ujiie K, Tomita K, Shiigai T. Effects of oral adsorbent AST-120 on the progression of chronic renal failure: a randomized controlled study. Kidney Int Suppl 1997;63:S188-90.
17. Cano A, Alcaraz O, Arnao MB. Free radical-scavenging activity of indolic compounds in aqueous and ethanolic media. Anal Bioanal Chem 2003;376:33-7.
18. Fukutomi J, Fukuda A, Fukuda S, Hara M, Terada A, Yoshida M. Scavenging activity of indole compounds against cisplatin-induced reactive oxygen species. Life Sci 2006;80:254-7.
19. Chyan YJ, Poeggeler B, Omar RA etal. Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid. J Biol Chem 1999;274:21937-42.
20. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 2001;53:135-59.
21. Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol 2003;91:7A-11A.
22. Lassegue B, Griendling KK. Reactive oxygen species in hypertension; An update. Am J Hypertens 2004;17:852-60.